A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

Clinical trial NCT04761198 · COMPLETED

Trial details

NCT number: NCT04761198
Sponsor: Mereo BioPharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Advanced Solid Tumor Metastatic Solid Tumor

Start date: 2021-03-23
Primary completion: 2023-10-30
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.